ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
rjames
|
279 |
89K |
12 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
279
|
89K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
rjames
|
279 |
89K |
14 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
279
|
89K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
rjames
|
279 |
89K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
279
|
89K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
rjames
|
279 |
89K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
279
|
89K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
rjames
|
163 |
54K |
19 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
163
|
54K
|
19
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
rjames
|
640 |
215K |
7 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
640
|
215K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
rjames
|
153 |
37K |
3 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
153
|
37K
|
3
|
|
ASX - By Stock
|
AXE |
Re:
Investor Briefing Oct23
|
|
rjames
|
52 |
14K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
52
|
14K
|
2
|
|
ASX - By Stock
|
AXE |
Re:
Investor Briefing Oct23
|
|
rjames
|
52 |
14K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
52
|
14K
|
1
|
|
ASX - By Stock
|
AXE |
Investor Briefing Oct23
|
|
rjames
|
52 |
14K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
52
|
14K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DMX 700
|
|
rjames
|
3 |
1.3K |
13 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
3
|
1.3K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Pause in Trading
|
|
rjames
|
26 |
7.5K |
5 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
26
|
7.5K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Closes SPP Oversubscribed
|
|
rjames
|
146 |
43K |
3 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
146
|
43K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
rjames
|
75 |
23K |
6 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
75
|
23K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
rjames
|
75 |
23K |
1 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
75
|
23K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
rjames
|
75 |
23K |
3 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
75
|
23K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
rjames
|
75 |
18K |
2 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
75
|
18K
|
2
|
|
ASX - By Stock
|
ROO |
Re:
Ann: Suspension from Official Quotation
|
|
rjames
|
58 |
20K |
5 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
58
|
20K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Clinical Study in Patients with COVID-19 Progresses
|
|
rjames
|
21 |
5.8K |
8 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
21
|
5.8K
|
8
|
|
ASX - By Stock
|
RNT |
Re:
Ann: Share Placement to Strategic Investor
|
|
rjames
|
257 |
81K |
8 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
257
|
81K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
27 11
|
|
rjames
|
12 |
2.9K |
7 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
12
|
2.9K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
|
|
rjames
|
627 |
260K |
1 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
627
|
260K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
|
|
rjames
|
627 |
260K |
4 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
627
|
260K
|
4
|
|
ASX - By Stock
|
CCA |
Re:
Ann: Strategic Acquisition - Company Presentation
|
|
rjames
|
235 |
81K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
235
|
81K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
rjames
|
29K |
13M |
10 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
29K
|
13M
|
10
|
|
ASX - By Stock
|
DXB Biotech |
Re:
Valuation post positive results
|
|
rjames
|
195 |
96K |
0 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
195
|
96K
|
0
|
|
ASX - By Stock
|
AXE |
Re:
Ann: Quantum devices successfully built for qubit control
|
|
rjames
|
52 |
16K |
0 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
52
|
16K
|
0
|
|
ASX - By Stock
|
AXE |
Re:
Ann: Quantum devices successfully built for qubit control
|
|
rjames
|
52 |
16K |
0 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
52
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study
|
|
rjames
|
286 |
88K |
4 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
286
|
88K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
rjames
|
218 |
57K |
8 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
218
|
57K
|
8
|
|
ASX - By Stock
|
CZN |
Re:
Ann: Section 708 Cleansing Notice
|
|
rjames
|
61 |
12K |
6 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
61
|
12K
|
6
|
|
ASX - By Stock
|
CZN |
Re:
takeover target for vale
|
|
rjames
|
165 |
79K |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
165
|
79K
|
1
|
|
ASX - By Stock
|
99L |
Re:
fair value 38c
|
|
rjames
|
3 |
3.3K |
1 |
13/06/18 |
13/06/18 |
ASX - By Stock
|
3
|
3.3K
|
1
|
|
ASX - By Stock
|
ISU |
Re:
takeover
|
|
rjames
|
113 |
58K |
1 |
01/06/18 |
01/06/18 |
ASX - By Stock
|
113
|
58K
|
1
|
|
ASX - By Stock
|
99L |
fair value 38c
|
|
rjames
|
3 |
3.3K |
1 |
01/06/18 |
01/06/18 |
ASX - By Stock
|
3
|
3.3K
|
1
|
|
ASX - By Stock
|
ISU |
Fair value $2.03
|
|
rjames
|
3 |
2.0K |
2 |
01/06/18 |
01/06/18 |
ASX - By Stock
|
3
|
2.0K
|
2
|
|
ASX - By Stock
|
VYS |
Vysarn last time round
|
|
rjames
|
3 |
2.1K |
0 |
14/12/17 |
14/12/17 |
ASX - By Stock
|
3
|
2.1K
|
0
|
|
Charts
|
PSL |
Re:
...HDY chart
|
|
rjames
|
459 |
162K |
0 |
29/11/17 |
29/11/17 |
Charts
|
459
|
162K
|
0
|
|
ASX - By Stock
|
QTK |
8 million again today
|
|
rjames
|
1 |
179 |
0 |
11/07/02 |
11/07/02 |
ASX - By Stock
|
1
|
179
|
0
|
|
ASX - By Stock
|
QTK |
options up 77%
|
|
rjames
|
0 |
111 |
0 |
10/07/02 |
10/07/02 |
ASX - By Stock
|
0
|
111
|
0
|
|
ASX - By Stock
|
QTK |
QTK - sudden buying
|
|
rjames
|
0 |
131 |
0 |
10/07/02 |
10/07/02 |
ASX - By Stock
|
0
|
131
|
0
|
|
General
|
|
Re:
Nostradamus predicted a Nuclear war this year.
|
|
rjames
|
34 |
1.8K |
0 |
27/05/02 |
27/05/02 |
General
|
34
|
1.8K
|
0
|
|